{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:23:48Z","timestamp":1771550628215,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jmig.2012.11.010","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T08:55:02Z","timestamp":1358326502000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Surgical Implications of the Potential New Tubal Pathway for Ovarian Carcinogenesis"],"prefix":"10.1016","volume":"20","author":[{"given":"Gautier","family":"Chene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kourosh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2012.11.010_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib5","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the Fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib11","doi-asserted-by":"crossref","first-page":"126295","DOI":"10.1155\/2010\/126295","article-title":"Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics","volume":"2010","author":"Gross","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactic removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in Fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA 1 and BRCA 2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/modpathol.2009.92","article-title":"PAX2 expression in low malignant potential ovarian tumors and low grade ovarian serous carcinomas","volume":"22","author":"Tung","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":"High grade fimbrial ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/PGP.0b013e3181a76fa2","article-title":"PAX2: a novel M\u00fcllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma","volume":"28","author":"Chivukula","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","article-title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","volume":"110","author":"Salvador","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","article-title":"Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including RSF-1 (HBXAP), Cyclin E and fatty acid synthase","volume":"23","author":"Sehdev","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib22","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/PAS.0b013e31825ec07a","article-title":"The diagnostic and biological implications of Laminin expression in serous tubal intraepithelial carcinoma","volume":"36","author":"Kuhn","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Gorgoulis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmig.2012.11.010_bib25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmig.2012.11.010_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/epi.5.2.11080","article-title":"\u03b3H2AX as a molecular marker of aging and disease","volume":"2","author":"Mah","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.jmig.2012.11.010_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2008.03.025","article-title":"Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy","volume":"76","author":"Clingen","year":"2008","journal-title":"Bioch Pharmacol"},{"key":"10.1016\/j.jmig.2012.11.010_bib28","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.jmig.2012.11.010_bib29","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmig.2012.11.010_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (Non uterine) serous carcinomas of tubal origine?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib31","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"Primary peritoneal high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PGP.0b013e318216d447","article-title":"P53 Signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary","volume":"30","author":"Leonhardt","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1525-1438.1997.00379.x","article-title":"Ovarian dysplasia: a review","volume":"7","author":"Deligdisch","year":"1997","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib36","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2012.11.010_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","article-title":"Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer","volume":"30","author":"Werness","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and non carriers of a BRCA1 or BRCA2 gene mutation","volume":"91","author":"Stratton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2012.11.010_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/IGC.0b013e3181990127","article-title":"Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk","volume":"19","author":"Chene","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(19890215)63:4<748::AID-CNCR2820630424>3.0.CO;2-8","article-title":"Characterization of ovarian dysplasia by interactive morphometry","volume":"63","author":"Deligdisch","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib41","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/1097-0142(19931201)72:11<3253::AID-CNCR2820721120>3.0.CO;2-1","article-title":"Ovarian dysplasia: nuclear texture analysis","volume":"72","author":"Deligdisch","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006254-197203000-00001","article-title":"The secondary Mullerian system","volume":"27","author":"Lauchlan","year":"1972","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jmig.2012.11.010_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: a unifying hypothesis","volume":"30","author":"Auersperg","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib44","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/IGC.0b013e31824d7269","article-title":"BRCA, the oviduct and the space and time continuum of pelvic serous carcinogenesis","volume":"22","author":"Crum","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13669-011-0004-1","article-title":"Ovarian cancer is an imported disease: fact or fiction?","volume":"1","author":"Kuhn","year":"2012","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1016\/j.jmig.2012.11.010_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jmig.2012.11.010_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for BRCA 1 and BRCA 2 mutation carriers; results from the international BRCA 1\/2 carrier Cohort Study","volume":"18","author":"Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jmig.2012.11.010_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc2946-c1","article-title":"The forgotten fallopian tube","volume":"11","author":"Dietl","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib49","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/humrep\/der274","article-title":"The post-reproductive Fallopian tube: better removed?","volume":"26","author":"Dietl","year":"2011","journal-title":"Human Reprod"},{"key":"10.1016\/j.jmig.2012.11.010_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0165-4608(96)00245-2","article-title":"High frequency of telomeric associations in human ovarian surface epithelial cells transformed by HPV oncogenes","volume":"95","author":"Wan","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jmig.2012.11.010_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1128\/jcm.33.4.1011-1013.1995","article-title":"Absence of human papillomavirus sequences in ovarian pathologies","volume":"33","author":"Trottier","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmig.2012.11.010_bib52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000292496","article-title":"Detection of HPV RNA in ovarian and endometrial carcinomas by reverse transcription polymerase chain reaction","volume":"38","author":"Lai","year":"1994","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jmig.2012.11.010_bib53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.onc.1200868","article-title":"20q gain associates with immortalization; 20q 13.2 amplification correlates with genome instability in HPV 16 E7 transformed human uroepithelial cells","volume":"14","author":"Savelieva","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jmig.2012.11.010_bib54","first-page":"239","article-title":"NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase inhibitions as likely mechanisms behind the acetaminophen and NSAID prevention of the ovarian cancer","volume":"51","author":"Altinoz","year":"2004","journal-title":"Neoplasma"},{"key":"10.1016\/j.jmig.2012.11.010_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2011.02.012","article-title":"Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA1 or 2 genes? Rationale and preliminary development","volume":"121","author":"Leblanc","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib56","unstructured":"Healthcare cost and utilization project (HCUP), 1988-2001: a federal-state-industry partnership in health data. Rockville, MD: Agency for healthcare research and quality. Available at: http:\/\/www.cdc.gov\/mnwr\/preview\/mmwhrtml\/ss5105a1.htm."},{"key":"10.1016\/j.jmig.2012.11.010_bib57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5122(00)00135-3","article-title":"Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy","volume":"36","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2012.11.010_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmig.2009.12.016","article-title":"Bilateral oophorectomy versus ovarian conservation: effects on long-term women's heath","volume":"17","author":"Parker","year":"2010","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2012.11.010_bib59","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2012.11.010_bib60","first-page":"23","article-title":"Sterilization in the United States","volume":"1","author":"Bartz","year":"2008","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.jmig.2012.11.010_bib61","first-page":"14","article-title":"Don't forget Fallopian tubes: a morphologic and immunohistochemical study about Fallopian tubes with genetic risk (BRCA mutation)","volume":"40","author":"Chene","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jmig.2012.11.010_bib62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ygyno.2012.03.009","article-title":"Peritoneal washing cytology\u00a0in patients with BRCA1 or BRCA2 mutations undergoing\u00a0risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility","volume":"125","author":"Landon","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2011.10.017","article-title":"The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian\/tubal cancer","volume":"124","author":"Manchanda","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.2002.6638","article-title":"Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy","volume":"85","author":"Colgan","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib66","first-page":"800","article-title":"Ovarian epithelial dysplasia: myth or reality?","volume":"36","author":"Chene","year":"2008","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jmig.2012.11.010_bib67","first-page":"296","article-title":"The role of the fallopian tube in ovarian cancer","volume":"10","author":"Tone","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib68","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2012.11.010_bib69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2012.11.010_bib70","first-page":"33","article-title":"Prophylactic oophorectomy in inherited breast\/ovarian cancer familie","volume":"17","author":"Struewing","year":"1995","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jmig.2012.11.010_bib71","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","article-title":"Primary peritoneal carcinoma afetr prophylactic oophorectomy in women with a family history of ovarian cancer: a report of the Gilda Radner Familial Ovarian Cancer Registry","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2009.12.023","article-title":"Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?","volume":"117","author":"Cass","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib73","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/ijgc-00009577-200609000-00034","article-title":"A substancial part of the fallopian tube is left after standard prophylactic bilateral salpingo-oophorectomy","volume":"16","author":"Gerritzen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/IGC.0b013e31824b4093","article-title":"Diathermy-induced injury may affect detection of occult yubal lesions at risk-reducing salpingo-oophorectomy","volume":"22","author":"Manchanda","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2012.11.010_bib75","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinomas in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2012.11.010_bib76","first-page":"605","article-title":"Optical biopsy in gynecology","volume":"195","author":"Deligdisch","year":"2011","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.jmig.2012.11.010_bib77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jgyn.2007.09.003","article-title":"The place of confocal microscopy in gynecology","volume":"37","author":"Ascencio","year":"2008","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jmig.2012.11.010_bib78","doi-asserted-by":"crossref","first-page":"90.e1","DOI":"10.1016\/j.ajog.2009.07.027","article-title":"In\u00a0vivo imaging of ovarian tissue using a novel confocal microlaparoscope","volume":"202","author":"Tanbakuchi","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2012.11.010_bib79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2010.12.333","article-title":"Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection","volume":"120","author":"McAlpine","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib80","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1470-2045(11)70222-4","article-title":"The tubal hypothesis of ovarian cancer: caution needed","volume":"12","author":"Collins","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmig.2012.11.010_bib81","article-title":"Early detection of ovarian cancer: tomorrow?","author":"Chene","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465012013234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465012013234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:36:34Z","timestamp":1761557794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465012013234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1553465012013234"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2012.11.010","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Implications of the Potential New Tubal Pathway for Ovarian Carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2012.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AAGL. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}